---
figid: PMC5350732__CTS-2-183-g003
figtitle: Gene transcripts associated with sensitivity to gefitinib and EGFR and/or
  head and neck cancer, identified from the genome‐wide statistical analysis, followed
  by pathway analysis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5350732
filename: CTS-2-183-g003.jpg
figlink: /pmc/articles/PMC5350732/figure/f3/
number: F3
caption: Gene transcripts associated with sensitivity to gefitinib and EGFR and/or
  head and neck cancer, identified from the genome‐wide statistical analysis, followed
  by pathway analysis. ADRB2 = adrenergic, beta‐2‐, receptor, surface; AREG = amphiregulin;
  ARNT2 = aryl‐hydrocarbon receptor nuclear translocator 2; CCNL1 = cyclin L1; CD82
  = CD82 molecule; CDH1 = E‐cadherin; CSTA = cystatin A; CTNND1 = catenin; CTTN =
  cortactin; EFNB2 = ephrin‐B2; EGFR = epidermal growth factor receptor; EGR1 = early
  growth response 1; ELF1 = E74‐like factor 1; ELF3 = E74‐like factor 3; FBN1 = fibrillin
  1; FGF2 = fibroblast growth factor 2; FYN = FYN oncogene related to SRC; GRB7 =
  growth factor receptor‐bound protein 7; GSTP1 = glutathione S‐transferase pi; HBEGF
  = heparin‐binding EGF‐like growth factor; HER3 = v‐erb‐b2 avian erythroblastic leukemia
  viral oncogene homolog 3; KRT4 = keratin 4; KRT13 = keratin 13; KRT16 = keratin
  16; LAMC2 = laminin; LY6D = lymphocyte antigen 6 complex; MMP13 = matrix metallopeptidase
  13; PLD1 = phospholipase D1; PTPN2 = protein tyrosine phosphatase, non‐receptor
  type 2; PTPN6 = protein tyrosine phosphatase, non‐receptor type 6; RAP2B = member
  of RAS oncogene family; RARG = retinoic acid receptor, gamma; RASSF1 = Ras association
  (RalGDS/AF‐6) domain family 1; RELA = v‐rel reticuloendotheliosis viral oncogene
  homolog A; S100A2 = S100 calcium‐binding protein A2; SERPINB3 = serpin peptidase
  inhibitor, clade B (ovalbumin), member 3; SERPINB4 = serpin peptidase inhibitor,
  clade B (ovalbumin), member 4; SMAD4 = SMAD, mothers against decapentaplegic homolog
  4; TGFA = transforming growth factor, alpha; TGFBR1 = transforming growth factor,
  beta receptor I; TIMP2 = TIMP metallopeptidase inhibitor 2; TIMP3 = TIMP metallopeptidase
  inhibitor 3; TOP2B = topoisomerase (DNA) II beta; TP73L = tumor protein p73‐like;
  VIM = vimentin; XDH = xanthine dehydrogenase.
papertitle: Identification of Biomarkers in Human Head and Neck Tumor Cell Lines That
  Predict For In Vitro Sensitivity to Gefitinib.
reftext: D. Mark Hickinson, et al. Clin Transl Sci. 2009 Jun;2(3):183-192.
year: '2009'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8350239
figid_alias: PMC5350732__F3
figtype: Figure
redirect_from: /figures/PMC5350732__F3
ndex: efe4fba5-df20-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5350732__CTS-2-183-g003.html
  '@type': Dataset
  description: Gene transcripts associated with sensitivity to gefitinib and EGFR
    and/or head and neck cancer, identified from the genome‐wide statistical analysis,
    followed by pathway analysis. ADRB2 = adrenergic, beta‐2‐, receptor, surface;
    AREG = amphiregulin; ARNT2 = aryl‐hydrocarbon receptor nuclear translocator 2;
    CCNL1 = cyclin L1; CD82 = CD82 molecule; CDH1 = E‐cadherin; CSTA = cystatin A;
    CTNND1 = catenin; CTTN = cortactin; EFNB2 = ephrin‐B2; EGFR = epidermal growth
    factor receptor; EGR1 = early growth response 1; ELF1 = E74‐like factor 1; ELF3
    = E74‐like factor 3; FBN1 = fibrillin 1; FGF2 = fibroblast growth factor 2; FYN
    = FYN oncogene related to SRC; GRB7 = growth factor receptor‐bound protein 7;
    GSTP1 = glutathione S‐transferase pi; HBEGF = heparin‐binding EGF‐like growth
    factor; HER3 = v‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 3;
    KRT4 = keratin 4; KRT13 = keratin 13; KRT16 = keratin 16; LAMC2 = laminin; LY6D
    = lymphocyte antigen 6 complex; MMP13 = matrix metallopeptidase 13; PLD1 = phospholipase
    D1; PTPN2 = protein tyrosine phosphatase, non‐receptor type 2; PTPN6 = protein
    tyrosine phosphatase, non‐receptor type 6; RAP2B = member of RAS oncogene family;
    RARG = retinoic acid receptor, gamma; RASSF1 = Ras association (RalGDS/AF‐6) domain
    family 1; RELA = v‐rel reticuloendotheliosis viral oncogene homolog A; S100A2
    = S100 calcium‐binding protein A2; SERPINB3 = serpin peptidase inhibitor, clade
    B (ovalbumin), member 3; SERPINB4 = serpin peptidase inhibitor, clade B (ovalbumin),
    member 4; SMAD4 = SMAD, mothers against decapentaplegic homolog 4; TGFA = transforming
    growth factor, alpha; TGFBR1 = transforming growth factor, beta receptor I; TIMP2
    = TIMP metallopeptidase inhibitor 2; TIMP3 = TIMP metallopeptidase inhibitor 3;
    TOP2B = topoisomerase (DNA) II beta; TP73L = tumor protein p73‐like; VIM = vimentin;
    XDH = xanthine dehydrogenase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARNT2
  - LAMC2
  - PTPN2
  - MMP13
  - GRB7
  - SERPINB4
  - GSTP1
  - FYN
  - CD82
  - CSTA
  - TP63
  - ERBB3
  - PTPN6
  - TGFBR1
  - ADRB2
  - CCNL1
  - MCM2
  - TGFA
  - VIM
  - AREG
  - CDH1
  - FZR1
  - S100A2
  - PLD1
  - PRKCSH
  - EGFR
  - KRT13
  - KRT33A
  - KRT16
  - LY6D
  - LY6G6D
  - FGF2
  - FGF13
  - GOT2
  - TAF1
  - SERPINB3
  - EFNB2
  - CTTN
  - ELF3
  - RASSF1
  - FBN1
  - TOP2B
  - SMAD4
  - RARG
  - RELA
  - TIMP2
  - ELF1
  - EFNA2
  - ELOF1
  - CTNND1
  - TMX2-CTNND1
  - TIMP3
  - OMA1
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - LONP1
---
